BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28101612)

  • 41. Elimination of β-mannose glycan structures in Pichia pastoris.
    Hopkins D; Gomathinayagam S; Rittenhour AM; Du M; Hoyt E; Karaveg K; Mitchell T; Nett JH; Sharkey NJ; Stadheim TA; Li H; Hamilton SR
    Glycobiology; 2011 Dec; 21(12):1616-26. PubMed ID: 21840970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation of TRS130, which encodes a component of the TRAPP II complex, activates transcription of OCH1 in Saccharomyces cerevisiae.
    Yamamoto K; Jigami Y
    Curr Genet; 2002 Nov; 42(2):85-93. PubMed ID: 12478387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Engineering the yeast Yarrowia lipolytica for the production of therapeutic proteins homogeneously glycosylated with Man₈GlcNAc₂ and Man₅GlcNAc₂.
    De Pourcq K; Vervecken W; Dewerte I; Valevska A; Van Hecke A; Callewaert N
    Microb Cell Fact; 2012 May; 11():53. PubMed ID: 22548968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-hypermannose glycosylation disruption enhances recombinant protein production by regulating secretory pathway and cell wall integrity in Saccharomyces cerevisiae.
    Tang H; Wang S; Wang J; Song M; Xu M; Zhang M; Shen Y; Hou J; Bao X
    Sci Rep; 2016 May; 6():25654. PubMed ID: 27156860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activity of recycling Golgi mannosyltransferases in the yeast endoplasmic reticulum.
    Karhinen L; Makarow M
    J Cell Sci; 2004 Jan; 117(Pt 2):351-8. PubMed ID: 14676282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-glycosylation humanization for production of therapeutic recombinant glycoproteins in Saccharomyces cerevisiae.
    Arico C; Bonnet C; Javaud C
    Methods Mol Biol; 2013; 988():45-57. PubMed ID: 23475713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [New approach to reveal genes that control cell wall biogenesis of the yeast Saccharomyces cerevisiae].
    Fomonov GV; Ter-Avanesian MD
    Mol Biol (Mosk); 2005; 39(5):859-68. PubMed ID: 16240719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A combined system for engineering glycosylation efficiency and glycan structure in Saccharomyces cerevisiae.
    Parsaie Nasab F; Aebi M; Bernhard G; Frey AD
    Appl Environ Microbiol; 2013 Feb; 79(3):997-1007. PubMed ID: 23204425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Saccharomyces cerevisiae Ybr004c and its human homologue are required for addition of the second mannose during glycosylphosphatidylinositol precursor assembly.
    Fabre AL; Orlean P; Taron CH
    FEBS J; 2005 Mar; 272(5):1160-8. PubMed ID: 15720390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. O-mannosyl glycans: from yeast to novel associations with human disease.
    Willer T; Valero MC; Tanner W; Cruces J; Strahl S
    Curr Opin Struct Biol; 2003 Oct; 13(5):621-30. PubMed ID: 14568618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Saccharomyces cerevisiae alpha1,6-mannosyltransferase has a catalytic potential to transfer a second mannose molecule.
    Kitajima T; Chiba Y; Jigami Y
    FEBS J; 2006 Nov; 273(22):5074-85. PubMed ID: 17042779
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of conditional cell lysis mutants of Saccharomyces cerevisiae as production hosts by modulating OCH1 and CHS3 expression.
    Luu VT; Moon HY; Yoo SJ; Choo JH; Thak EJ; Kang HA
    Appl Microbiol Biotechnol; 2019 Mar; 103(5):2277-2293. PubMed ID: 30706115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring of the tissue distribution of fibroblast growth factor containing a high mannose-type sugar chain produced in mutant yeast.
    Takamatsu S; Chiba Y; Ishii T; Nakayama K; Yokomatsu-Kubota T; Makino T; Fujibayashi Y; Jigami Y
    Glycoconj J; 2004; 20(6):385-97. PubMed ID: 15238703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pleiotropic roles of N-glycans for enzyme activities and stabilities of MIPC synthases, Csh1 and Sur1/Csg1, in Saccharomyces cerevisiae.
    Uemura S; Moriguchi T
    Glycobiology; 2022 Aug; 32(9):778-790. PubMed ID: 35713525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural analysis of N-/O-glycans assembled on proteins in yeasts.
    Thak EJ; Kim J; Lee DJ; Kim JY; Kang HA
    J Microbiol; 2018 Jan; 56(1):11-23. PubMed ID: 29299842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring Protein Dynamics in Protein
    Castells-Ballester J; Zatorska E; Meurer M; Neubert P; Metschies A; Knop M; Strahl S
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30322079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. O-mannosyl glycans in mammals.
    Endo T
    Biochim Biophys Acta; 1999 Dec; 1473(1):237-46. PubMed ID: 10580142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tailoring N-Glycan Biosynthesis for Production of Therapeutic Proteins in Saccharomyces cerevisiae.
    Piirainen MA; Salminen H; Frey AD
    Methods Mol Biol; 2019; 1923():227-241. PubMed ID: 30737743
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural Analysis of Free N-Glycans in α-Glucosidase Mutants of Saccharomyces cerevisiae: Lack of the Evidence for the Occurrence of Catabolic α-Glucosidase Acting on the N-Glycans.
    Hossain TJ; Harada Y; Hirayama H; Tomotake H; Seko A; Suzuki T
    PLoS One; 2016; 11(3):e0151891. PubMed ID: 27010459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo characterization of the GPI assembly defect in yeast mcd4-174 mutants and bypass of the Mcd4p-dependent step in mcd4Delta cells.
    Wiedman JM; Fabre AL; Taron BW; Taron CH; Orlean P
    FEMS Yeast Res; 2007 Jan; 7(1):78-83. PubMed ID: 17311586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.